Eledon Pharmaceuticals, Inc.
NASDAQ:ELDN
5.3 (USD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| -40.326 | -87.966 | -34.506 | -22.811 | -16.011 | -14.065 | -13.116 | -37.959 | -45.087 | -23.296 | -15.725 | -9.649 |
| Depreciation & Amortization
| 0.374 | 0.373 | 0.195 | 0.183 | 0.182 | 0.011 | 0.022 | 0.171 | 0.109 | 0.021 | 0.01 | 0.009 |
| Deferred Income Tax
| -9.893 | 0 | -2.354 | -0.404 | 0 | 0 | 0 | 0.352 | 0.072 | 0 | -0.238 | -0.21 |
| Stock Based Compensation
| 6.545 | 8.153 | 7.904 | 3.171 | 1.308 | 1.543 | 0.579 | 3.002 | 2.901 | 2.108 | 0.238 | 0.21 |
| Change In Working Capital
| -4.917 | 2.368 | -0.152 | -0.18 | -1.203 | 0.618 | -2.475 | -2.084 | 1.004 | 0.204 | 0.001 | 0.097 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -2.6 | 2.081 | 2.143 | -0.039 | -1.392 | 1.094 | -1.958 | -0.778 | 0.443 | 0.76 | -0.759 | -0.119 |
| Other Working Capital
| -2.317 | 0.287 | -2.295 | -0.141 | 0.189 | -0.476 | -0.517 | -1.306 | 0.561 | -0.556 | 0.76 | 0.216 |
| Other Non Cash Items
| 8.69 | 48.648 | 6.151 | 4.829 | 1.867 | 0.471 | 0.049 | -0.002 | -0.235 | -0.158 | 0.238 | 0.21 |
| Operating Cash Flow
| -39.527 | -28.424 | -28.913 | -15.212 | -13.857 | -11.893 | -14.941 | -36.52 | -41.236 | -21.121 | -15.476 | -9.333 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.017 | -0.565 | -0.025 | -0.023 | -0.008 |
| Acquisitions Net
| 0 | 0 | 0 | 11.035 | 0 | 0 | 23.25 | -0.002 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -78.287 | 0 | 0 | 0 | 0 | 0 | 0 | -0.5 | -39.875 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 33 | 0 | 0 | 0 | 0 | 0 | 0 | 36.2 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -0.045 | 0 | 0 | 11.035 | 0 | 0 | 0.008 | 0.002 | -0.07 | -0.15 | -0.03 | 0 |
| Investing Cash Flow
| -45.287 | 0 | 0 | 11.035 | 0 | 0 | 23.258 | 35.683 | -40.51 | -0.175 | -0.053 | -0.008 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| 0 | 0 | 0 | -0 | 0 | 0 | 0 | -2.93 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 33.017 | 0 | -0.449 | 9 | 9.676 | 7.491 | 4.75 | 0 | 0.464 | 97.929 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | -0.025 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.033 | 0 | -0.45 | 100.606 | 0.01 | 0.071 | 3.119 | 0.037 | 0.513 | -3.13 | 35.591 | 18.779 |
| Financing Cash Flow
| 33.017 | 0 | -0.449 | 109.581 | 9.676 | 7.562 | 7.869 | 0.037 | 0.513 | 94.799 | 35.591 | 18.779 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -51.797 | -28.424 | -29.362 | 105.404 | -4.181 | -4.331 | 16.186 | -0.8 | -81.233 | 73.503 | 20.062 | 9.438 |
| Cash At End Of Period
| 4.612 | 56.409 | 84.833 | 114.195 | 8.791 | 12.972 | 17.303 | 23.223 | 24.023 | 105.256 | 31.753 | 11.691 |